Hannah Valantine - Insider Trading & Ownership

Location
1305 O'brien Drive, Menlo Park, CA
Summary
The estimated net worth of Hannah Valantine is at least $1.31M dollars as of November 14, 2025. Hannah Valantine is the Director of CareDx, Inc. and owns shares of CareDx, Inc. (CDNA) stock worth about $747K. Hannah Valantine is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $514K. Hannah Valantine is the Director of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. and owns shares of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) stock worth about $46.3K.
Signature
/s/ Will Solis, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Hannah Valantine

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CDNA CareDx, Inc. Director $747K -$203K -21.3% Jun 18, 2025
BBIO BridgeBio Pharma, Inc. Director $514K -$2.48M -82.8% Nov 12, 2025
PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Director $46.3K Jun 4, 2025

Insider Transactions Reported by Hannah Valantine:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.